Skip to content

Author

Moshe Giladi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Case report Open access Jul 2026

Further Support for Association of DAND5 with Autosomal Recessive Laterality Disorders

Background: Laterality defects are rare congenital malformations that encompass congenital heart defects (CHDs) together with abnormalities of visceral organ arrangement (situs inversus or situs ambiguous). These defects may be isolated or part of a syndromic presentation with multisystem involvement. While over 50 genes have been implicated in laterality disorders, across multiple modes of inheritance, many cases remain molecularly undiagnosed. We sought to elucidate the molecular basis of dextrocardia, CHDs and visceral heterotaxy in two unrelated individuals of Arab-Muslim descent. Methods: Detailed clinical phenotyping and exome sequencing (ES) were performed for each of the probands, followed by familial segregation analysis. Results: ES revealed a shared homozygous variant in the Dan Domain Family Member 5 (DAND5) gene (NM_152654.3): c.396_397dup, p.(Tyr133SerfsTer11). DAND5 encodes a member of the Cerberus-related DAN protein family, which is involved in the establishment of left body asymmetry. This frameshift variant introduces a premature stop codon within the final exon, which is predicted to escape nonsense-mediated decay (NMD), resulting in a truncated protein lacking the functional DAN domain. Conclusions: DAND5 has recently been suggested as a candidate gene in heterotaxy and CHDs. Our findings further support biallelic loss of function variants in DAND5 autosomal recessive laterality defects.

O. Chorin, Yoav Bolkier, U. Katz et al. · 0 citations
Open access Jul 2026

A multipurpose probe for identification and mechanistic analysis of prenylation inhibitors.

Protein prenylation is a critical post-translational modification that controls many cancer-related signalling pathways and represents an important therapeutic target currently lacking effective pharmacological agents. Here, we establish the fluorescent prenyl diphosphate analogue MANT-O-GPP as a multipurpose probe for simultaneous analysis of ligand binding and catalysis in geranylgeranyltransferase I (GGTaseI) and farnesyltransferase (FTase). Using a tryptophan-to-MANT-O-GPP FRET assay, we found that MANT-O-GPP bound to GGTaseI and FTase with high affinity and reported occupancy of the isoprenoid donor site, as confirmed by displacement with the native substrates. In parallel, a FRET-based activity assay employing CFP-tagged protein substrates enabled direct monitoring of prenyl transfer and product formation. Notably, the known inhibitor L-778123 blocked catalysis without displacing MANT-O-GPP, demonstrating that the combined platform distinguishes prenyl-site competitors from inhibitors acting through the adjacent protein-substrate region. This fluorescence-based system provides a practical, mechanistically informative, and high-throughput-compatible platform for prenyltransferase inhibitor discovery.

Ruba Yehia, Moshe Giladi, Y. Haitin · 0 citations